BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Katagiri D, Hinoshita F. Gemcitabine-induced thrombotic microangiopathy with nephrotic syndrome. CEN Case Rep 2018;7:217-20. [PMID: 29766468 DOI: 10.1007/s13730-018-0332-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 MacDougall KN, Schwartz B, Harewood J, Bukhari Z, Neculiseanu E. A Case of Gemcitabine-Induced Thrombotic Microangiopathy Treated With Ravulizumab in a Patient With Stage IV Pancreatic Cancer. Cureus 2021;13:e13031. [PMID: 33680585 DOI: 10.7759/cureus.13031] [Reference Citation Analysis]
2 Madkhali MA. A rare case report of gemcitabine-induced thrombotic microangiopathies. SAGE Open Med Case Rep 2021;9:2050313X211013208. [PMID: 34104442 DOI: 10.1177/2050313X211013208] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Horino T, Inotani S, Ishihara M, Terada Y. Gemcitabine‐induced renal thrombotic microangiopathy. Nephrology. [DOI: 10.1111/nep.14043] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Sharma P, Uppal NN, Wanchoo R, Shah HH, Yang Y, Parikh R, Khanin Y, Madireddy V, Larsen CP, Jhaveri KD, Bijol V; Northwell Nephrology COVID-19 Research Consortium. COVID-19-Associated Kidney Injury: A Case Series of Kidney Biopsy Findings. J Am Soc Nephrol 2020;31:1948-58. [PMID: 32660970 DOI: 10.1681/ASN.2020050699] [Cited by in Crossref: 103] [Cited by in F6Publishing: 77] [Article Influence: 51.5] [Reference Citation Analysis]
5 Cervantes CE, Kant S, Atta MG. The Link Between Conventional and Novel Anti-Cancer Therapeutics with Thrombotic Microangiopathy. Drug Metab Lett 2021;14:97-105. [PMID: 34279209 DOI: 10.2174/1872312814666210716141633] [Reference Citation Analysis]